1.Unilateral Pulmonary Agenesis Combined with other Unusual Anomalies: An autopsy report.
Ik Su KIM ; Sang Han LEE ; In Soo SHU
Korean Journal of Pathology 1996;30(2):166-168
Pulmonary agenesis is a very rare anomaly. It is defined as total absence of the pulmonary parenchyma, vascular structures, and bronchi beyond the carina. We experienced a case of right pulmonary agenesis in association with other congenital defects who died at 1 day of age. The other defects included: esophageal atresia, tracheoesophageal fistula, cardiac malformation, anal atresia and a malformed left thumb. The cardiac malformations were a type of Pentalogy of Fallot, composed of right ventricular hypertrophy, ventricular septal defect, an overiding of aorta, pulmonary atresia, and an atrial septal defect. Hand roentgenograms of the malformed left thumb showed an unarticulated metacarpopharyngeal joint. This unique combination of anomalies is extremely rare.
2.A Case of Plexiform Neurofibroma of the Right Upper Eyelid and Orbit in Neurofibromatosis.
Dong Seok KIM ; Sang Won KIM ; Han Ik BAE
Korean Journal of Dermatology 1986;24(5):734-738
We have experienced a case of plexiform neurofibrorna of the right upper eyelid and orbit in a 12-year-old girl who had typical skin features of neurofibromatosis and no family history. The non-pulsating proptosis of the right eye and diffuse thickening with hypertrophy of the upper lid, had increased insiduciusly since the birth on. Biopsy taken from eyelirl lesion showed the features of plexiform neurofibroma. Skull X-ray and brain computerized tomogram showed that the right orbit was wider, with the enlarged mass and defects in orbital roof and lesser and greater wings of the sphenoid bone. The surgical excision of the right eyelid lesion was performed.
Biopsy
;
Brain
;
Child
;
Exophthalmos
;
Eyelids*
;
Female
;
Humans
;
Hypertrophy
;
Neurofibroma, Plexiform*
;
Neurofibromatoses*
;
Orbit*
;
Parturition
;
Skin
;
Skull
;
Sphenoid Bone
3.Survey result on the prevalence of hyperlipidemia and other risk factors of coronary artery disease among Korean population.
Jin Q KIM ; Jung Han SONG ; Han Ik CHO ; Sang In KIM
Korean Journal of Clinical Pathology 1991;11(2):341-347
No abstract available.
Coronary Artery Disease*
;
Coronary Vessels*
;
Hyperlipidemias*
;
Prevalence*
;
Risk Factors*
4.Experience of directed donor program in surgery of patients with primary liver cancer.
Seon Ho LEE ; Nam Yong LEE ; Kyou Sup HAN ; Han Ik CHO ; Sang In KIM
Korean Journal of Blood Transfusion 1992;3(2):129-136
No abstract available.
Humans
;
Liver Neoplasms*
;
Liver*
;
Tissue Donors*
5.In vitro assessment of five-day stored platelets.
Sang In KIM ; Kyou Sup HAN ; Han Ik CHO ; Young Chul OH ; Ki Hong KIM
Korean Journal of Blood Transfusion 1991;2(1):29-36
No abstract available.
6.Detection of human papillomaviruses in cervical interepithelial neoplasia and invasive carcinoma by in situ polymerase chain reaction.
Joon Cheol PARK ; Tae Sang KIM ; Dong Ja KIM ; Han Ik BAE ; Jeong Ran KIM
Korean Journal of Obstetrics and Gynecology 2000;43(10):1738-1743
No abstract available.
Humans*
;
Polymerase Chain Reaction*
7.Microwave stimulated iron staining of plastic embedded bone marrow section.
Han Ik CHO ; Myong Ok SHIM ; Woon Heung SONG ; Sang In KIM
Korean Journal of Clinical Pathology 1991;11(1):79-81
No abstract available.
Bone Marrow*
;
Iron*
;
Microwaves*
;
Plastics*
8." TOTI " Method for Difficult Orotracheal Intubation in Adult Patients.
Korean Journal of Anesthesiology 1991;24(2):379-383
This report is a prospective study comparing conventional direct laryngoseopy with tube-over-tube intubation ("TOTI") method in 42 male patients, whose tracheas were difficult to intubate. ("TOTI") method using two different-sized endotracheal tubes, the newly devised technique has not been mentioned yet. And the comparative studies have not been performed to evaluate relative efficacy, speed, or incidence of complications for the conventional versus "TOTI" method in endotracheal intubation. Overall number of attempts (mean+/-SE) in conventional group was 3.62+/-0.37(range; 1-8), while "TOTI" one was 1.1+/-0.07 (range; 1-2). The time required for intubation ranged from 25 to 64 seconds in TOTI group and 37 to 2015 sec in conventional one, average (mean+/-SE) 37.19+/-1.87 and 542.71+/-111.54sec, respectively. No complications of endotracheal intubation occured in "TOTI" group, whereas in coventional one there occurred fourteen patients with sore throat, seven with hoarseness and five with temporary short-lived dysrhythmia.
Adult*
;
Hoarseness
;
Humans
;
Incidence
;
Intubation*
;
Intubation, Intratracheal
;
Male
;
Pharyngitis
;
Prospective Studies
;
Trachea
9.Characterization of acute leukemia through automatic assessment of peripheral blood cells by USE of Technicon H-1.
Yoon Sun YANG ; Hee Jung KANG ; Woon Hong SONG ; Han Ik CHO ; Sang In KIM
Korean Journal of Clinical Pathology 1991;11(3):567-573
No abstract available.
Blood Cells*
;
Leukemia*
10.Antigenicity of the G2 Glycoprotein in Cell - Mediated Immune Response Against Hantanvirus Infection.
Ik Sang KIM ; Myung Sik CHOI ; Myung Ju YI ; Tae Hee HAN
Journal of the Korean Society for Microbiology 1998;33(6):619-624
Hemorrhagic fever with renal syndrom is an acute febrile disease which is caused by Hantanvirus and several other viruses that belong to the genus Hantavirus. Gl and G2 glycoproteins of Hantanvirus have been thought to be involved in protective immunity against Hantanvirus infection. In this study, the antigenicity of G1 and G2 glycoproteins in cell mediated immune response was investigated. When peripheral blood mononuclear cell fraction from recovered hemorrhagic fever with renal syndrome patient was cultivated with a recombinant protein containing amino-terminal 78 amino acids of G2 glycoprotein, these cells were activated to proliferate and secreted significant amount of interleukin-2 and interferon-r. These results suggest that T cell epitope exists in the amino-terminal region of G2 glycoprotein.
Amino Acids
;
Epitopes, T-Lymphocyte
;
Fever
;
Glycoproteins*
;
Hantavirus
;
Hemorrhagic Fever with Renal Syndrome
;
Humans
;
Interleukin-2